Medical Cannabis

Articles

The 2022 Canna Pharma Conference was held October 12-13 in San Diego, California.

Highlights from Canna Pharma 2022: Driving Cannabis Science and Therapeutics Forward

In the work presented here, the author shares research from collecting reports from the New Jersey State laboratory (the Department of Health’s Environmental and Chemical Laboratory Services), which has conducted testing for the state’s medicinal program. He documented an average variance of 20% in potency levels from different samples of the same test lot.

Degree of Variance in THC Levels in Samples Taken from Single Lots  of Medical Cannabis

Dr. Stephen Barnhill, founder, chairman, and CEO of Apollon Formularies, plc., explained to Cannabis Science Conference East 2022 attendees, his findings on how cannabis and mushrooms can be the ultimate weapon in the war against cancer.

Cannabis and Mushrooms and Their Tale to Treating Cancer

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


In this interview, Dr. David “Dedi” Meiri discusses his important work at Technion, challenges and opportunities in cannabis research, and a preview of his upcoming presentation for CSC East.

2022 CSC East Plenary Speaker Highlight: Dr. Dedi Meiri

Otha Smith III shares his personal journey with medical cannabis and how it led to founding the Tetragram app.

Tetragram Provides Cannabis Users a Safe Environment to Explore the Medicinal Benefits of the Plant

In this interview, Abbey Roudebush, Director of Government Affairs for Americans for Safe Access (ASA), explains the goals of ASA and provides an in-depth analysis of their annual State of the States report.

Medical Cannabis Is Here and It’s Here to Stay: How Americans for Safe Access, the Nation’s Largest Member-Based Cannabis Advocacy Organization, Protects Patient Rights

In this article, regulatory requirements are explored as they are meant to create confidence that cannabis and cannabis-infused products are safe to use.

Improving Quality in Cannabis Testing Laboratories: Making ISO/IEC 17025 Work for Your Laboratory and Customers

Dr. Richard van Breemen from the Department of Pharmaceutical Sciences in the Oregon State University College of Pharmacy discusses his COVID-19 and cannabis research.

Cannabinoids and COVID-19: An Interview with Professor Richard van Breemen of Oregon State University

Dr. Alison Draisin discusses her work at the forefront of cannabis assisted psychotherapy and psychedelic assisted psychotherapy.

Reaching a Higher Dimension:  Conversation with Dr. Alison Draisin, Leading Assisted Psychedelic Psychotherapist

In this piece, we touch on the benefits and challenges associated with autoflowering genetics, and provide justification for why these unique varietals may be the catalyst for making cannabis medicine more accessible and approachable for the general population. 